Height as a Risk Factor for Osteosarcoma
Authors:
- Alessandra LonghiALAlessandra Longhi
- Andrea PasiniAPAndrea Pasini
- Alessandro CicognaniACAlessandro Cicognani
- Federico BaronioFBFederico Baronio
- Andrea PellacaniAPAndrea Pellacani
- Nicola BaldiniNicola Baldini
- Gaetano BacciGBGaetano Bacci
- 1 June 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 27 (6) , 314-318
Abstract
Previous investigations have suggested that osteosarcoma may be associated with a taller stature, but the relationship between height and osteosarcoma remains controversial. Height at diagnosis was evaluated in a continuous series of 962 osteosarcoma subjects treated between 1981 and 2001. Patients diagnosed during growth (group 1) were separated from those diagnosed in adulthood (group 2). Height (H) and final height (FH) were expressed as standard deviation scores (SDS), calculated by national reference data. Group 1 subjects were above the 50th centile and their mean H-SDS values (0.31 ± 1.1) were significantly higher than the mean FH-SDS values (P < 0.0001) of the group 2 subjects, both in males and females. In contrast, the mean FH-SDS (0.01 ± 1.1) of group 2 did not differ from that of the reference population. The highest incidence of osteosarcoma was at 12.5 years in females, 14.5 years in males. These data confirm previous observations of an association between osteosarcoma development and height, at least in growing individuals. The higher incidence during the pubertal spurt, in the anatomic sites of greater growth and in taller individuals, suggests that growth factors play an important role in the pathogenesis of this bone cancer.Keywords
This publication has 26 references indexed in Scilit:
- Stature of young people with malignant bone tumorsPediatric Blood & Cancer, 2003
- Italian cross-sectional growth charts for height, weight and BMI (6–20 y)European Journal of Clinical Nutrition, 2002
- Redundancy of autocrine loops in human osteosarcoma cellsInternational Journal of Cancer, 1999
- Human osteosarcoma (U‐2 OS) cells express both insulin‐like growth factor‐I (IGF‐I) receptors and insulin‐like growth factor‐II/mannose‐6‐phosphate (IGF‐II/M6P) receptors and synthesize IGF‐II: Autocrine growth stimulation by IGF‐II via the IGF‐I receptorJournal of Cellular Physiology, 1994
- Inhibition of Metastatic Behavior of Murine Osteosarcoma by HypophysectomyJNCI: Journal of the National Cancer Institute, 1992
- Comparative Aspects of OsteosarcomaClinical Orthopaedics and Related Research, 1991
- The Effect of Chemotherapy on Growth in the Skeletally Immature IndividualClinical Orthopaedics and Related Research, 1991
- Insulinlike Growth Factor I: A Potent Mitogen for Human Osteogenic SarcomaJNCI: Journal of the National Cancer Institute, 1990
- Prognostic factors in osteosarcoma: A review of 20 years' experience at the university of pittsburgh health center hospitalsCancer, 1975
- Stature and malignant tumors of bone in childhood and adolescenceCancer, 1967